Hg. Xie et al., Arg(389)Gly beta(1)-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo, PHARMACOGEN, 11(3), 2001, pp. 191-197
There are marked interethnic differences in beta (1)-adrenclceptor-mediated
responsiveness, with sensitivity decreased in African-Americans and increa
sed in Chinese compared with Caucasians, Therefore, the frequency of a comm
on naturally occurring polymorphism of the human beta (1)-adrenoceptor gene
(Arg(389)Gly), which has functional importance in vitro, was determined in
194 African-Americans, 316 Caucasian-Americans, 221 Hispanic-Americans and
142 Chinese. African-Americans were found to hare a significantly lower fr
equency of the Arg(389) allele than the other three ethnic groups (all P <
0.01), In the populations studied, the order of the distribution of the Arg
(389) allele was: Chinese (74%) > Caucasians (72%) > Hispanics (67%) > Afri
can-Americans (58%). To determine the functional significance of the Arg(38
9)Gly beta (1)-adrenoceptsr polymorphism in-vivo heart rate responses to ex
ercise were compared in healthy subjects homozygous for the Arg (n = 9) and
Gly (n = 8) alleles, Heart rate response to exercise was not affected by g
enotype (P = 0.4). Although ethnic differences in the frequency of the beta
(1)-adrenoceptor Arg(389)Gly polymorphism exist, the polymorphism does Hot
appear to have functional significance in healthy subjects and therefore m
ay not contribute to ethnic differences in response to drugs acting through
the beta (1)-adrenoceptor, Pharmacogenetics 11:191-197 (C); 2001 Lippincot
t Williams & Wilkins.